Marijuana and Mental Health
WHAT THE EVIDENCE SHOWS: PSYCHOSIS, DEPRESSION, SUICIDE, AND ADDICTION
Marijuana and mental health are now tied together in thousands of peer-reviewed studies. Today’s high-potency THC is linked to psychosis, depression, suicide, and addiction. Here is what the research says, with sources.
- Marijuana today averages four times the THC it did in 1995. Concentrates reach 99 percent.
- Daily use of high-potency products is linked to a four- to five-fold increase in psychosis, and the link holds across countries and decades.
- Adult users report suicidal thoughts at twice the national rate. Teen users face higher odds of depression and suicide attempts.
- About 30 percent of users develop an addiction. 19.3 million Americans have one now.
- Randomized trials do not support marijuana as a treatment for anxiety, depression, or PTSD. The Lancet Psychiatry says there is no universally safe level of use.
Why the old studies understate the risk
Most research on marijuana and mental health was done on a weaker drug than the one sold today. Average THC in DEA-seized marijuana quadrupled between 1995 and 2022. Concentrates, vapes, and dabs run 55 to 99 percent. A 30 percent THC product delivers roughly three times the THC of a 10 percent product, even after users adjust how much they take.
THC potency has quadrupled, and concentrates are in a different league
Average THC content by product and year
Sources: DEA potency monitoring via NIDA (2024); Chandra et al. (2019); NIDA (2020). Compiled in SAM’s Impact Report 2026-27. Full data: Marijuana potency: how strong is weed today?
Use has changed too. In 2025, 21.4 million Americans used marijuana daily or nearly every day, more than smoke cigarettes daily and more than drink daily. The studies below come from populations using less, less often. The risk today is likely higher than they show.
Daily marijuana use now exceeds daily smoking and daily drinking
Americans aged 12 and older reporting daily or near-daily use, 2025, in millions
Source: SAMHSA, 2025 National Survey on Drug Use and Health, detailed tables.
Does marijuana cause psychosis?
This is the most studied link between marijuana and mental health, and the most consistent. The pattern holds in Sweden in 1987, Europe in 2019, Denmark in 2023, and Ontario in 2025: the more THC and the more often, the higher the risk. Researchers describe marijuana as a contributing cause of psychosis, not the only cause.
Daily users of high-potency marijuana had “four-times higher odds of psychosis” than never-users. The odds ratio was 4.8.
Di Forti et al., The Lancet Psychiatry, 2019. 11 sites, 901 first-episode psychosis patients, 1,237 controls.
People treated in an ER for marijuana-induced psychosis were 241.6 times more likely to develop a schizophrenia-spectrum disorder within three years. Any marijuana-related ER visit: 14.3 times.
Canadian Medical Association Journal, 2025. 9.8 million Ontario residents.
Of schizophrenia cases among men 21 to 30 might have been prevented by preventing marijuana addiction. About one in five among young men overall.
Hjorthøj et al., Psychological Medicine, 2023. Danish national registry, 6.9 million people.
Teens (12 to 19) who used marijuana had 11 times the risk of a psychotic disorder compared with non-users.
McDonald et al., Psychological Medicine, 2024.
Of patients first treated for marijuana-induced psychosis were later diagnosed with a schizophrenia-spectrum disorder, often more than a year later.
Arendt et al., British Journal of Psychiatry, 2005. 535 cases.
Share of Danish schizophrenia cases linked to marijuana addiction, 1995 to 2010, tracking rising potency and use.
Hjorthøj et al., JAMA Psychiatry, 2021.
Marijuana psychosis is not rare and not always temporary. Continued use after a first episode raises the odds of relapse and hospitalization. Stopping is protective.
Marijuana, depression, and suicide risk
The industry markets THC for stress and sleep. The population data point the other way. The studies below follow people over time and adjust for prior mental illness, so they are not simply catching people who were depressed to begin with.
Adult marijuana users report suicidal thoughts, plans, and attempts at about twice the national rate
Past-year rates among adults, 2023
Source: SAMHSA, 2023 National Survey on Drug Use and Health. Compiled in SAM’s Impact Report 2026-27.
Teens who use marijuana face higher odds of depression and suicide as young adults
Pooled odds ratios from 11 longitudinal studies, 23,317 participants. 1.0 means no difference from non-users.
Source: Gobbi et al., JAMA Psychiatry, 2019. Anxiety (OR 1.18) was not statistically significant.
Higher odds of suicidal ideation and of a suicide attempt among adolescents who used marijuana, after accounting for pre-existing depression.
Drug and Alcohol Dependence, 2025 (Sorbonne)
Risk of death by suicide within five years among people who received hospital care for marijuana addiction. Overall mortality was nearly three times higher. More on marijuana deaths.
JAMA Network Open, 2025. 11.6 million Ontario residents.
Adults with marijuana addiction who had a major depressive episode in the past year, compared with all adults. More than half (52.5%) had a mental illness.
SAMHSA, 2023 NSDUH
Higher risk of a later depressive disorder and of an anxiety disorder among teens who used marijuana, and roughly double the risk of a new psychotic or bipolar disorder.
Young-Wolff et al., JAMA Health Forum, February 2026. 463,396 California adolescents followed to age 25.
Colorado is the cautionary tale. Since legalization, suicides among adolescents aged 15 to 19 have nearly doubled, and marijuana is now the most common substance found in the toxicology of Colorado youth who die by suicide. Before legalization it was alcohol.
How marijuana affects the teenage brain
The brain is not finished until about age 25, and THC acts on the system that wires it. Every major finding on youth use points the same direction: earlier and heavier use, worse outcomes, and some of the damage does not reverse. For the state-by-state numbers on teen use, see Youth Marijuana Use.
Average decline from childhood to adulthood among persistent adolescent-onset users. Points lost did not return after quitting.
Meier et al., PNAS, 2012 (Dunedin cohort)
Higher chance of mental health problems, and 86 percent higher chance of physical health problems, among people who began at least monthly use before age 15.
McGill University, JAMA Network Open, 2025
Of heavy lifetime users and recent users showed reduced brain activity on working-memory tasks in the largest neuroimaging study of its kind.
University of Colorado, JAMA Network Open, 2025
The odds of dropping out of high school among adolescent users, plus 39 percent higher odds of lower grades and 28 percent lower odds of attending university.
Chan et al., 2024 meta-analysis
Greater odds of major depression, suicidal ideation, trouble concentrating, truancy, and arrest among teens with even non-disordered use.
Sultan et al., Columbia University, JAMA Network Open, 2023
More likely to have an anxiety disorder, and PTSD, among children whose mothers had marijuana addiction during pregnancy. See marijuana during pregnancy.
Journal of Affective Disorders, 2025
Is marijuana addictive?
Yes. That is the National Institute on Drug Abuse’s position, and the numbers are large. About 30 percent of users develop a use disorder. Starting before 18 raises the odds four- to seven-fold. Higher potency means higher risk, and the risk is highest for the youngest users.
Americans met clinical criteria for marijuana use disorder in 2025, up 2.6 million since 2021. One in three users. One in seven adults aged 18 to 25.
SAMHSA, 2025 NSDUH
Of regular users experience withdrawal when they stop: irritability, insomnia, anxiety, cravings.
Bahji et al., JAMA Network Open, 2020 meta-analysis
Higher risk of a dementia diagnosis within five years among adults over 45 who needed hospital care for marijuana. Such visits rose 26.7-fold among people 65 and older from 2008 to 2021.
JAMA Neurology, 2025. 6.1 million Ontario adults.
Even as more young people in legal states need treatment for marijuana addiction, fewer are receiving it.
Mennis et al., 2023
Does marijuana treat anxiety, depression, or PTSD?
No. The claim that marijuana relieves anxiety, depression, or PTSD is the industry’s oldest sales pitch. The randomized trials do not support it.
“Evidence from randomized clinical trials does not support the use of cannabis or cannabinoids for most conditions” for which they are promoted.
Hsu et al., Therapeutic Use of Cannabis and Cannabinoids, JAMA, November 2025
People randomly assigned a medical marijuana card had “increased incidence and severity of CUD and resulted in no significant improvement in pain, anxiety, or depressive symptoms.”
Gilman et al., JAMA Network Open, 2022
Two studies of military personnel with PTSD found elevated suicidal thoughts and behaviors among those using marijuana.
Allan et al., Depression and Anxiety, 2019; Gentes et al., 2016
“Very little evidence” that cannabinoids improve depressive disorders, anxiety disorders, ADHD, Tourette syndrome, PTSD, or psychosis.
Black et al., The Lancet Psychiatry, 2019 systematic review
What marijuana legalization changed for mental health
Legalization means commercialization: more potent products, more stores, more advertising, more daily use. The mental health data followed.
Teens living farther from marijuana stores have fewer psychotic disorders
Prevalence of psychotic disorders among California youth, relative to teens living within 5 minutes of a retailer
Source: USC and Kaiser Permanente, Substance Use & Misuse, 2025. Survey of about 100,000 California youth.
Increase in marijuana use disorder among 12- to 17-year-olds in states after recreational legalization.
Cerdá et al., JAMA Psychiatry, 2020
Increase in past-month use among youth (12 to 17) and young adults (18 to 25) associated with recreational legalization.
Pawar et al., JAACAP, 2024 meta-analysis
After Massachusetts opened retail sales, marijuana-related disorders “disproportionately increased among adolescents, aged 12 to 17 years, presenting for a psychiatric emergency.”
Mass General Brigham, January 2026
Share of new schizophrenia cases attributable to marijuana addiction in Ontario before and after Canada legalized. Among men 19 to 24, the share reached 18.9 percent.
Myran et al., JAMA Network Open, 2025. 13.6 million Ontario residents.
Admissions to Guernsey’s adult mental health ward in 2023 were likely linked to marijuana, up from 4 percent in 2019.
States of Guernsey report via BBC News, 2024
Local control works. Potency limits work. Distance from a dispensary is measurable protection for a teenager.
The numbers are families
More stories from families, and how to share yours through the Parent Action Network.
What SAM is calling for
- Potency caps. Vermont and Connecticut cap concentrates at 60 percent and flower at 30 percent. Every legal state should, and none should sell 99 percent THC to anyone.
- Mental health warning labels on every THC product, modeled on tobacco: psychosis, addiction, suicide risk, and the developing brain.
- A pause on new legalization until the mental health data from Colorado, Washington, and Canada are honestly reckoned with.
- Real-time public data on marijuana-related psychiatric emergencies, psychosis admissions, potency, and treatment demand, reported by every legal state.
- No federal rescheduling that hands the industry tax breaks and a “medicine” label the trials do not support.
- Close the hemp loophole so intoxicating THC is not sold in gas stations without any of the above.
Where to go next
Join the Parent Action Network for talking points and the warning signs of marijuana psychosis.
Download the one-pagers and book a SAM training.
Read the 2026-27 Impact Report and the Local Control Toolkit.
Every figure has a primary source below. Interviews and data: info@learnaboutsam.org.
Marijuana and mental health: frequently asked questions
Does marijuana cause schizophrenia?
Marijuana use is strongly and consistently linked to schizophrenia, and studies that follow people over time show use comes first. Daily users of high-potency products have about four times the odds of a psychotic disorder. Danish researchers estimate up to 30 percent of schizophrenia cases among young men could be prevented by preventing marijuana addiction. Scientists describe it as a contributing cause, not the only cause.
Can marijuana help with anxiety or depression?
Randomized trials say no. A 2025 review in JAMA found trial evidence does not support marijuana for most conditions it is promoted for. A randomized trial that gave people medical marijuana cards found no improvement in anxiety or depression and an increase in addiction. Population studies link marijuana use to higher rates of depression and anxiety later on.
How common is marijuana addiction?
About 30 percent of users develop a use disorder, according to NIDA. In 2025, 19.3 million Americans met clinical criteria, more than for any drug except alcohol. Starting before age 18 raises the risk four- to seven-fold.
Is today’s marijuana really that different?
Yes. Average THC in seized marijuana rose from about 4 percent in 1995 to over 16 percent in 2022. Concentrates and vapes run 55 to 99 percent. Psychosis and addiction risk rise with potency, and most older research was done on a much weaker product.
What are the signs of marijuana psychosis?
Paranoia, hearing or seeing things that are not there, disorganized thinking, and detachment from reality, usually during or after heavy use of high-potency products. It can last days or become a lasting disorder. Anyone with these symptoms should stop using and see a doctor. In an emergency, call 911 or 988.
Does SAM want to arrest people who use marijuana?
No. SAM opposes incarceration for use and supports treatment and prevention. What we oppose is a commercial industry selling high-potency THC with no potency limits, no honest warnings, and no accountability for the mental health harms documented here.
Marijuana today is a high-potency drug with documented mental health harms. Get the facts to the people who need them.
Download the Impact ReportJoin the Parent Action NetworkBook a training
Sources
- Di Forti M, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI). The Lancet Psychiatry. 2019;6(5):427-436.
- Canadian Medical Association Journal. 2025;197(27). Emergency department visits for cannabis use and schizophrenia (Ontario).
- Hjorthøj C, et al. Association between cannabis use disorder and schizophrenia stronger in young males than in females. Psychological Medicine. 2023.
- Hjorthøj C, et al. Development over time of the population-attributable risk fraction for cannabis use disorder in schizophrenia in Denmark. JAMA Psychiatry. 2021.
- McDonald AJ, et al. Age-dependent association of cannabis use with risk of psychotic disorder. Psychological Medicine. 2024.
- Arendt M, et al. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders. British Journal of Psychiatry. 2005.
- The Lancet Psychiatry. 2026. Review of cannabis use and mental health outcomes (“no universally safe level of cannabis use”).
- SAMHSA. 2023 and 2025 National Survey on Drug Use and Health, detailed tables.
- Gobbi G, et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood. JAMA Psychiatry. 2019;76(4):426-434.
- Drug and Alcohol Dependence, 2025 (Sorbonne). Adolescent cannabis use and suicidality.
- JAMA Network Open, 2025. Cannabis use disorder and mortality (Ontario, 11.6 million).
- Young-Wolff KC, et al. Adolescent cannabis use and risk of psychotic, bipolar, depressive, and anxiety disorders. JAMA Health Forum. February 2026.
- Myran DT, et al. Changes in incident schizophrenia diagnoses associated with cannabis use disorder after cannabis legalization. JAMA Network Open. 2025;8(2):e2457868.
- Meier MH, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. PNAS. 2012.
- McGill University. JAMA Network Open. 2025. Early frequent cannabis use and health outcomes.
- University of Colorado. JAMA Network Open. 2025. Cannabis use and brain function during working memory.
- Chan GCK, et al. Adolescent cannabis use and educational outcomes: meta-analysis. 2024.
- Sultan RS, et al. Nondisordered cannabis use among US adolescents. JAMA Network Open. 2023.
- Journal of Affective Disorders, 2025. Prenatal cannabis use disorder and offspring anxiety and PTSD.
- National Institute on Drug Abuse. Is marijuana addictive?
- Bahji A, et al. Prevalence of cannabis withdrawal symptoms. JAMA Network Open. 2020.
- JAMA Neurology, 2025. Cannabis-related acute care and dementia risk (Ontario).
- Mennis J, et al. 2023. Treatment admissions for cannabis use disorder.
- Hsu G, et al. Therapeutic use of cannabis and cannabinoids. JAMA. November 2025.
- Gilman JM, et al. Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms. JAMA Network Open. 2022.
- Allan NP, et al. Depression and Anxiety. 2019;36(11); Gentes EL, et al. 2016.
- Black N, et al. Cannabinoids for the treatment of mental disorders. The Lancet Psychiatry. 2019.
- USC and Kaiser Permanente. Substance Use & Misuse. 2025. DOI 10.1080/10826084.2025.2505145.
- Cerdá M, et al. JAMA Psychiatry. 2020. Recreational marijuana legalization and cannabis use disorder.
- Pawar AB, et al. Journal of the American Academy of Child and Adolescent Psychiatry. 2024;63(11).
- Mass General Brigham, January 2026. Adolescent psychiatric emergencies after Massachusetts commercialization.
- Xu et al. European Journal of Health Economics. 2025. THC intake by product potency.
- NIDA. Cannabis potency data, 2024; Chandra S, et al. 2019; NIDA 2020.
- SAM. Lessons Learned from State Marijuana Legalization: Impact Report 2026-2027.

